The effectriveness and cost effectiveness of imatinib in chronic myeloid leukaemia: a systematic review

G. Garside, A. Round, K. Dalziel, K. Stein, Pamela Lee Royle

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1-162
Number of pages161
JournalHealth Technology Assessment
Volume6
Issue number33
Publication statusPublished - 2002

Cite this

Garside, G., Round, A., Dalziel, K., Stein, K., & Royle, P. L. (2002). The effectriveness and cost effectiveness of imatinib in chronic myeloid leukaemia: a systematic review. Health Technology Assessment, 6(33), 1-162.